247 related articles for article (PubMed ID: 23569193)
1. Tubal ligation and risk of ovarian cancer subtypes: a pooled analysis of case-control studies.
Sieh W; Salvador S; McGuire V; Weber RP; Terry KL; Rossing MA; Risch H; Wu AH; Webb PM; Moysich K; Doherty JA; Felberg A; Miller D; Jordan SJ; ; ; Goodman MT; Lurie G; Chang-Claude J; Rudolph A; Kjær SK; Jensen A; Høgdall E; Bandera EV; Olson SH; King MG; Rodriguez-Rodriguez L; Kiemeney LA; Marees T; Massuger LF; van Altena AM; Ness RB; Cramer DW; Pike MC; Pearce CL; Berchuck A; Schildkraut JM; Whittemore AS;
Int J Epidemiol; 2013 Apr; 42(2):579-89. PubMed ID: 23569193
[TBL] [Abstract][Full Text] [Related]
2. Tubal ligation and salpingectomy and the risk of epithelial ovarian cancer and borderline ovarian tumors: a nationwide case-control study.
Madsen C; Baandrup L; Dehlendorff C; Kjaer SK
Acta Obstet Gynecol Scand; 2015 Jan; 94(1):86-94. PubMed ID: 25256594
[TBL] [Abstract][Full Text] [Related]
3. Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case-control studies.
Pearce CL; Templeman C; Rossing MA; Lee A; Near AM; Webb PM; Nagle CM; Doherty JA; Cushing-Haugen KL; Wicklund KG; Chang-Claude J; Hein R; Lurie G; Wilkens LR; Carney ME; Goodman MT; Moysich K; Kjaer SK; Hogdall E; Jensen A; Goode EL; Fridley BL; Larson MC; Schildkraut JM; Palmieri RT; Cramer DW; Terry KL; Vitonis AF; Titus LJ; Ziogas A; Brewster W; Anton-Culver H; Gentry-Maharaj A; Ramus SJ; Anderson AR; Brueggmann D; Fasching PA; Gayther SA; Huntsman DG; Menon U; Ness RB; Pike MC; Risch H; Wu AH; Berchuck A;
Lancet Oncol; 2012 Apr; 13(4):385-94. PubMed ID: 22361336
[TBL] [Abstract][Full Text] [Related]
4. Risk of epithelial ovarian cancer Type I and II after hysterectomy, salpingectomy and tubal ligation-A nationwide case-control study.
Darelius A; Kristjansdottir B; Dahm-Kähler P; Strandell A
Int J Cancer; 2021 Oct; 149(8):1544-1552. PubMed ID: 34152012
[TBL] [Abstract][Full Text] [Related]
5. Tubal ligation and ovarian cancer risk in a large cohort: Substantial variation by histological type.
Gaitskell K; Green J; Pirie K; Reeves G; Beral V;
Int J Cancer; 2016 Mar; 138(5):1076-84. PubMed ID: 26378908
[TBL] [Abstract][Full Text] [Related]
6. Tubal ligation and ovarian cancer risk in African American women.
McNamara C; Abbott SE; Bandera EV; Qin B; Peres LC; Camacho F; Moorman PG; Alberg AJ; Barnholtz-Sloan JS; Bondy M; Cote ML; Funkhouser E; Peters ES; Schwartz AG; Schildkraut JM; Terry P
Cancer Causes Control; 2017 Oct; 28(10):1033-1041. PubMed ID: 28871344
[TBL] [Abstract][Full Text] [Related]
7. Tubal ligation, hysterectomy and epithelial ovarian cancer in the New England Case-Control Study.
Rice MS; Murphy MA; Vitonis AF; Cramer DW; Titus LJ; Tworoger SS; Terry KL
Int J Cancer; 2013 Nov; 133(10):2415-21. PubMed ID: 23650079
[TBL] [Abstract][Full Text] [Related]
8. Risk of ovarian cancer after salpingectomy and tubal ligation: Prospects on histology and time since the procedure.
Duus AH; Zheng G; Baandrup L; Faber MT; Kjær SK
Gynecol Oncol; 2023 Oct; 177():125-131. PubMed ID: 37683548
[TBL] [Abstract][Full Text] [Related]
9. Reduced risk of ovarian cancer in women with a tubal ligation or hysterectomy. The World Health Organization Collaborative Study of Neoplasia and Steroid Contraceptives.
Rosenblatt KA; Thomas DB
Cancer Epidemiol Biomarkers Prev; 1996 Nov; 5(11):933-5. PubMed ID: 8922304
[TBL] [Abstract][Full Text] [Related]
10. Should All Cases of High-Grade Serous Ovarian, Tubal, and Primary Peritoneal Carcinomas Be Reclassified as Tubo-Ovarian Serous Carcinoma?
Moss EL; Evans T; Pearmain P; Askew S; Singh K; Chan KK; Ganesan R; Hirschowitz L
Int J Gynecol Cancer; 2015 Sep; 25(7):1201-7. PubMed ID: 26035124
[TBL] [Abstract][Full Text] [Related]
11. Reproductive risk factors for epithelial ovarian cancer according to histologic type and invasiveness.
Modugno F; Ness RB; Wheeler JE
Ann Epidemiol; 2001 Nov; 11(8):568-74. PubMed ID: 11709277
[TBL] [Abstract][Full Text] [Related]
12. Tubal ligation and risk of ovarian cancer in carriers of BRCA1 or BRCA2 mutations: a case-control study.
Narod SA; Sun P; Ghadirian P; Lynch H; Isaacs C; Garber J; Weber B; Karlan B; Fishman D; Rosen B; Tung N; Neuhausen SL
Lancet; 2001 May; 357(9267):1467-70. PubMed ID: 11377596
[TBL] [Abstract][Full Text] [Related]
13. Cigarette smoking and risk of ovarian cancer: a pooled analysis of 21 case-control studies.
Faber MT; Kjær SK; Dehlendorff C; Chang-Claude J; Andersen KK; Høgdall E; Webb PM; Jordan SJ; ; ; Rossing MA; Doherty JA; Lurie G; Thompson PJ; Carney ME; Goodman MT; Ness RB; Modugno F; Edwards RP; Bunker CH; Goode EL; Fridley BL; Vierkant RA; Larson MC; Schildkraut J; Cramer DW; Terry KL; Vitonis AF; Bandera EV; Olson SH; King M; Chandran U; Kiemeney LA; Massuger LF; van Altena AM; Vermeulen SH; Brinton L; Wentzensen N; Lissowska J; Yang HP; Moysich KB; Odunsi K; Kasza K; Odunsi-Akanji O; Song H; Pharaoh P; Shah M; Whittemore AS; McGuire V; Sieh W; Sutphen R; Menon U; Gayther SA; Ramus SJ; Gentry-Maharaj A; Pearce CL; Wu AH; Pike MC; Risch HA; Jensen A;
Cancer Causes Control; 2013 May; 24(5):989-1004. PubMed ID: 23456270
[TBL] [Abstract][Full Text] [Related]
14. Contraception methods, beyond oral contraceptives and tubal ligation, and risk of ovarian cancer.
Ness RB; Dodge RC; Edwards RP; Baker JA; Moysich KB
Ann Epidemiol; 2011 Mar; 21(3):188-96. PubMed ID: 21109450
[TBL] [Abstract][Full Text] [Related]
15. Tubal ligation and the risk of ovarian carcinoma.
Cornelison TL; Natarajan N; Piver MS; Mettlin CJ
Cancer Detect Prev; 1997; 21(1):1-6. PubMed ID: 9043756
[TBL] [Abstract][Full Text] [Related]
16. The effect of tubal ligation on the incidence of epithelial cancer of the ovary.
Koch M; Starreveld AA; Hill GB; Jenkins H
Cancer Detect Prev; 1984; 7(4):241-5. PubMed ID: 6488215
[TBL] [Abstract][Full Text] [Related]
17. Tubal ligation and incidence of 26 site-specific cancers in the Million Women Study.
Gaitskell K; Coffey K; Green J; Pirie K; Reeves GK; Ahmed AA; Barnes I; Beral V
Br J Cancer; 2016 Apr; 114(9):1033-7. PubMed ID: 27115569
[TBL] [Abstract][Full Text] [Related]
18. Oral contraceptive use, reproductive history, and risk of epithelial ovarian cancer in women with and without endometriosis.
Modugno F; Ness RB; Allen GO; Schildkraut JM; Davis FG; Goodman MT
Am J Obstet Gynecol; 2004 Sep; 191(3):733-40. PubMed ID: 15467532
[TBL] [Abstract][Full Text] [Related]
19. Reproductive characteristics in relation to ovarian cancer risk by histologic pathways.
Merritt MA; De Pari M; Vitonis AF; Titus LJ; Cramer DW; Terry KL
Hum Reprod; 2013 May; 28(5):1406-17. PubMed ID: 23315066
[TBL] [Abstract][Full Text] [Related]
20. Pelvic Inflammatory Disease and the Risk of Ovarian Cancer and Borderline Ovarian Tumors: A Pooled Analysis of 13 Case-Control Studies.
Rasmussen CB; Kjaer SK; Albieri V; Bandera EV; Doherty JA; Høgdall E; Webb PM; Jordan SJ; Rossing MA; Wicklund KG; Goodman MT; Modugno F; Moysich KB; Ness RB; Edwards RP; Schildkraut JM; Berchuck A; Olson SH; Kiemeney LA; Massuger LF; Narod SA; Phelan CM; Anton-Culver H; Ziogas A; Wu AH; Pearce CL; Risch HA; Jensen A;
Am J Epidemiol; 2017 Jan; 185(1):8-20. PubMed ID: 27941069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
